Vol 10, No 3 (2024)
Case report
Published online: 2024-08-21

open access

Page views 301
Article views/downloads 139
Get Citation

Connect on Social Media

Connect on Social Media

A benign form of epidermolysis bullosa pruriginosa with a novel mutation in COL7A1 gene in a Polish family: a case series and literature review

Izabela Błażewicz1, Krzysztof Kanabaj1, Adrian Karamon1, Ewa Grzybek-Duda2, Roman J. Nowicki1
Forum Dermatologicum 2024;10(3):97-100.

Abstract

Epidermolysis bullosa pruriginosa is an extremely rare form of dystrophic epidermolysis bullosa. Its cause is the underlying mutation, most often in the COL7A1 gene. Based upon a specific type of mutation in a patient (missense, non-sense, frameshift, splice-site mutations), a distinct, specific phenotype can be observed. This study presents a case series of three family members from the Pomerania region in Poland, with a novel missense mutation of p.Val2402Gly/-c.7205T > G in exon 94 of the COL7A1 gene.

Article available in PDF format

View PDF Download PDF file

References

  1. Kim WB, Alavi A, Walsh S, et al. Epidermolysis bullosa pruriginosa: a systematic review exploring genotype-phenotype correlation. Am J Clin Dermatol. 2015; 16(2): 81–87.
  2. Fine JD, Eady RAJ, Bauer EA, et al. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol. 2008; 58(6): 931–950.
  3. Tey HL, Lee AD, Almaani N, et al. Epidermolysis bullosa pruriginosa masquerading as psychogenic pruritus. Arch Dermatol. 2011; 147(8): 956–960.
  4. Marinkovich MP, Bauer EA. Epidermolysis bullosa. In: Fitzpatrick’s dermatology in general medicine. 7th ed. McGraw-Hill, New York 2008: 505–516.
  5. Zhou AG, Little AJ, Antaya RJ. Epidermolysis bullosa pruriginosa treated with dupilumab. Pediatr Dermatol. 2021; 38(2): 526–527.
  6. Shehadeh W, Sarig O, Bar J, et al. Treatment of epidermolysis bullosa pruriginosa-associated pruritus with dupilumab. Br J Dermatol. 2020; 182(6): 1495–1497.
  7. Wang Y, Zhou M, Zhang Li, et al. Amelioration of dystrophic epidermolysis bullosa pruriginosa symptoms with dupilumab: a case report. Dermatol Ther. 2021; 34(6): e15130.
  8. Caroppo F, Milan E, Giulioni E, et al. A case of dystrophic epidermolysis bullosa pruriginosa treated with dupilumab. J Eur Acad Dermatol Venereol. 2022; 36(5): e365–e367.